39 related articles for article (PubMed ID: 23061601)
1. Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
Bhowmick M; Stawikowska R; Tokmina-Roszyk D; Fields GB
Chembiochem; 2015 May; 16(7):1084-92. PubMed ID: 25766890
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinase 13 Inhibitors for Modulation of Osteoclastogenesis: Enhancement of Solubility and Stability.
Knapinska AM; Singh C; Drotleff G; Blanco D; Chai C; Schwab J; Herd A; Fields GB
ChemMedChem; 2021 Apr; 16(7):1133-1142. PubMed ID: 33331147
[TBL] [Abstract][Full Text] [Related]
3. Towards third generation matrix metalloproteinase inhibitors for cancer therapy.
Overall CM; Kleifeld O
Br J Cancer; 2006 Apr; 94(7):941-6. PubMed ID: 16538215
[TBL] [Abstract][Full Text] [Related]
4. 4-Thiazolidinone Derivatives as MMP Inhibitors in Tissue Damage: Synthesis, Biological Evaluation and Docking Studies.
Incerti M; Crascì L; Vicini P; Aki E; Yalcin I; Ertan-Bolelli T; Cardile V; Graziano ACE; Panico A
Molecules; 2018 Feb; 23(2):. PubMed ID: 29443898
[TBL] [Abstract][Full Text] [Related]
5. Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors.
Fischer T; Riedl R
ChemMedChem; 2013 Sep; 8(9):1457-61, 1572. PubMed ID: 23894097
[No Abstract] [Full Text] [Related]
6. Structure-Based Optimization and Biological Evaluation of Potent and Selective MMP-7 Inhibitors for Kidney Fibrosis.
Abe-Sato K; Tabuse H; Kanazawa H; Kamitani M; Endo M; Tokura S; Wakabayashi S; Yahara T; Takeda T; Hitaka K; Gunji E; Kojima N; Oka Y
J Med Chem; 2023 Nov; 66(21):14653-14668. PubMed ID: 37861435
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of di- and triacrylamides with tertiary amine cores and their evaluation as monomers in dental adhesive interfaces.
Fugolin APP; Navarro O; Logan MG; Huynh V; França CM; Ferracane JL; Pfeifer CS
Acta Biomater; 2020 Oct; 115():148-159. PubMed ID: 32853802
[TBL] [Abstract][Full Text] [Related]
8. Whitening and anti-wrinkle activities of ferulic acid isolated from Tetragonia tetragonioides in B16F10 melanoma and CCD-986sk fibroblast cells.
Park HJ; Cho JH; Hong SH; Kim DH; Jung HY; Kang IK; Cho YJ
J Nat Med; 2018 Jan; 72(1):127-135. PubMed ID: 28884442
[TBL] [Abstract][Full Text] [Related]
9. Cinnamide Derivatives as Mammalian Arginase Inhibitors: Synthesis, Biological Evaluation and Molecular Docking.
Pham TN; Bordage S; Pudlo M; Demougeot C; Thai KM; Girard-Thernier C
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27690022
[TBL] [Abstract][Full Text] [Related]
10. Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.
Xie XW; Wan RZ; Liu ZP
ChemMedChem; 2017 Aug; 12(15):1157-1168. PubMed ID: 28722301
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation.
Fischer T; Riedl R
Molecules; 2019 Jun; 24(12):. PubMed ID: 31216704
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of ferulic Acid amides as selective matrix metalloproteinase inhibitors.
Shi ZH; Li NG; Shi QP; Tang H; Tang YP; Li W; Yin L; Yang JP; Duan JA
Med Chem; 2013 Nov; 9(7):947-54. PubMed ID: 23061601
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.
Shi ZH; Li NG; Shi QP; Tang H; Tang YP; Li W; Yin L; Yang JP; Duan JA
Bioorg Med Chem Lett; 2013 Mar; 23(5):1206-11. PubMed ID: 23375794
[TBL] [Abstract][Full Text] [Related]
14. Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase.
Mendes DE; Wong-On-Wing A; Berkman CE
J Enzyme Inhib Med Chem; 2016; 31(1):167-71. PubMed ID: 25815671
[TBL] [Abstract][Full Text] [Related]
15. Monoamine Oxidase Inhibitory Activity of Ferulic Acid Amides: Curcumin-Based Design and Synthesis.
Badavath VN; Baysal İ; Uçar G; Mondal SK; Sinha BN; Jayaprakash V
Arch Pharm (Weinheim); 2016 Jan; 349(1):9-19. PubMed ID: 26592858
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
